ultima pharmaceuticals semaglutide Semaglutide: Injection Home Kit – NativeMed Brazilian federal court denies semaglutide

Nat Commun 11:498 Lee YZ, Yang CW, Chang HY et al (2014) Discovery of selective inhibitors of glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells

It is also used in a treatment called glutathione IV drip, in which glutathione is infused through an IV drip

Common adverse effects included nausea, diarrhea and vomiting, which are consistent with similar therapies

Secondary findings include a 75.8% reduction in WOMAC pain scores in participants with knee osteoarthritis, a 72% prediabetes-to-normoglycemia reversal rate, and an approximately 20% reduction in LDL cholesterol attributed to glucagon-receptor-driven PCSK9 degradation